Eucomed Board welcomes three new members

Press release

At the Eucomed Annual General Assembly on 17 October, Mr Moreira-Rato was elected to fill the position vacated by Stéphane Thiroloix on the Board’s Advisory Committee. The Board also voted to appoint Dr Sherif to replace Miguel Bernabeu while Assobiomedica, represented by Mr Mazzoletti, was elected to take up the national association seat formerly held by Medicoindustrien, which was represented by Louise Feilberg Levy.

A native of Portugal, Mr Moreira-Rato has enjoyed a 31-year career in healthcare in progressively senior roles, across a wide range of geographies. Prior to joining Smith & Nephew, he served as President, DePuy Synthes, EMEA, where he led the merger and integration of DePuy and Synthes across the EMEA region.

Dr Sherif joined Alcon as President for the EMEA region after gaining 18 years of experience in the pharmaceuticals sector which culminated in three years as President of Novartis Pharmaceuticals, Canada, prior to his move to Alcon. He has held myriad roles with Novartis since 2002, heading up several units including the Transplant and Infectious Disease Unit in Latin America, and Novartis’ Vaccines and Diagnostics Division for Latin America in 2007.

Founded in 1984, Italian medical technology industry association Assobiomedica’s mission is to serve as a strategic partner for Italian healthcare system stakeholders in promoting cultural, social and economic innovation, as well as research and development. Assobiomedica will be represented by Mr Mazzoletti of Sorin Group, who brings 15 years of experience in several senior positions across the medtech and pharmaceutical industries.

“The Eucomed Board is pleased to welcome these three highly qualified professionals as new members.” said Eucomed Chairman Rob ten Hoedt. “We look forward to their hands-on support in promoting the value of the medical technology industry to a range of stakeholdersThe Board also wants to extend its sincere thanks to our departing members whose contributions to Eucomed have been vital to the organisation’s success.”